隻藥得左
但咁樣值幾多錢,就唔知了
---
https://finance.yahoo.com/healthcare/articles/sellas-gps-cuts-death-risk-125915492.htmlSellas said the treatment was generally well tolerated, with no new safety concerns.
Most treatment-related side effects were mild or moderate, with reactions mainly at the injection site, the company said.
Sellas said the results were statistically significant, with a hazard ratio of 0.59
Sellas Life Sciences (SLS) said on Tuesday that its experimental cancer vaccine, Galinpepimut-S (GPS), significantly improved overall survival in patients with acute myeloid leukemia (AML), with the biotech firm eyeing a potential regulatory filing in the first half of next year.